Results 281 to 290 of about 67,507 (290)
Some of the next articles are maybe not open access.
Enzalutamide in Castration-Resistant Prostate Cancer
New England Journal of Medicine, 2018Giacomo, Bregni +2 more
openaire +4 more sources
[Castration resistant prostate cancer 2011].
Aktuelle Urologie, 2011Our understanding of - as well as our approach to - castration resistant prostate cancer is currently undergoing major changes. New drugs like the CYP-17 inhibitor abiraterone have shown that even in the "hormone refractory" stage the progression of prostate cancer is still driven by signaling of the androgen receptor.
openaire +1 more source
Denosumab in castration-resistant prostate cancer
The Lancet, 2012Athanassios, Kyrgidis +1 more
openaire +2 more sources

